China’s Top Regulator Upholds Tough Stance Against 'Redundant' Clinical Trials

PD-1 Overcrowding A Growing Issue

 
• By Dexter Jie Yan
clinical trial progress
Chinese regulator vows to continuously raise review requirements to prevent drain on clinical resources. • Source: Alamy

More from China

More from Asia